Over the past years, together with the group of Dr. Michael Weller at the USZ, the Snijder Lab has developed a new way to directly test the effects of hundreds of drugs on patient GBM tumor material, a technique we call Pharmacoscopy. We have started to collect the data to investigate if the drug responses we measure outside of the patient reflect the actual clinical response of the patient. This PHRT project aims at further validating Pharmacoscopy as a predictive ‘functional precision medicine’ platform, and for the discovery of new treatment options for GBM.